Delivery Order SPE2DX22D0099-SPE2D826FAA5F
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $10,873.56 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,038.72 on October 6, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is not set-aside restricted, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, will...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,296.75 by the Defense Logistics Agency's Medical Supply Chain on July 16, 2025, with an ultimate completion date of July 17, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,635.42 on September 8, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $35,097.32 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside delivery order operates under firm fixed pricing and represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The work will be...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $44,402.40 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's Corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,246.49 by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $2,458.82 by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate office in...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency's Medical Supply Chain division, with an ultimate completion date of September 4, 2025. This non-competitive, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a potential value of $999,999,999.00 through December 2026. The work will be...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAA5FDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,156.19 on October 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), involves the supply of pharmaceutical products and medical supplies to support federal military and healthcare system requirements. The contract was competitively awarded without set-aside designation and is scheduled for completion by October 14, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's principal IDC vehicle with DLA Troop Support Medical enables global pharmaceutical support for military healthcare programs and serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard. This delivery order exemplifies the company's ongoing role as a major vendor fulfilling federal medical supply needs through flexible contract mechanisms that support defense and civilian healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 10/13/25 |